Traws Pharma, Inc. — Director's Dealing 2016

Jan 28, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2016-01-26

Reporting Person: Kumar Ramesh (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-01-26	Stock Option (right to buy)	$0.65	A	146440	Acquired	2026-01-26	Common Stock (146440)	Direct

Footnotes

F1: These options vest, 25% on January 26, 2016 and 75% on December 31, 2016.